SMO-specific sdRNA conjugates (long-acting, sc, alcoholic liver disease) (Extend Biosciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSMO-specific sdRNA conjugates (long-acting, sc, alcoholic liver disease) (Extend Biosciences)
Drug Alias NameEXT-500
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionSmoothened receptor modulators
TargetsSmoothened receptor
Therapy Area/IndicationsHepatitis, Alcoholic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExtend Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExtend Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHepatitis, Alcoholic

Other Information

ATC CodeN/A
Related LinksN/A